CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 4,241	$ 5,038	$ 7,914	$ 6,416
Sales and marketing	1,683	564	3,727	607
General and administrative	3,675	872	7,303	2,439
Total operating expenses	9,599	6,474	18,944	9,462
Loss from operations	(9,599)	(6,474)	(18,944)	(9,462)
Interest expense, net	(329)	(1)	(646)	(2)
Change in fair value of SAFEs		(2,821)		(5,313)
Gain on loan forgiveness		647		647
Loss before provision (benefit) from income taxes	(9,928)	(8,649)	(19,590)	(14,130)
Provision (benefit) from income taxes		1		(150)
Net loss	(9,928)	(8,650)	(19,590)	(13,980)
Cumulative preferred dividends allocated to Series A Preferred Shareholders		(394)		(782)
Net loss Available to Common Stockholders, basic and diluted	$ (9,928)	$ (9,044)	$ (19,590)	$ (14,762)
Net loss per share attributable to common shareholders, basic	$ (0.42)	$ (0.84)	$ (0.83)	$ (1.38)
Net loss per share attributable to common shareholders, diluted	$ (0.42)	$ (0.84)	$ (0.83)	$ (1.38)
Weighted-average shares used in computing net loss per share, basic	23,592,995	10,730,818	23,498,978	10,707,996
Weighted-average shares used in computing net loss per share, diluted	23,592,995	10,730,818	23,498,978	10,707,996